Chronic myeloid leuk, BCR/ABL-positive, not achieve remis

This code signifies a persistent, slow-progressing cancer of the blood and bone marrow, specifically chronic myeloid leukemia (CML), that is characterized by the presence of the Philadelphia chromosome (BCR/ABL fusion gene). The "not having achieved remission" component indicates that the disease is still active and has not responded to treatment to the point of being undetectable.

Apply this code for patients diagnosed with CML who are confirmed to be BCR/ABL-positive and whose disease remains active despite treatment, without reaching a state of remission. Documentation should explicitly state CML, BCR/ABL positivity, and the current status as "not in remission" or "active disease."

• Ensure documentation specifies "BCR/ABL-positive" for accurate coding; otherwise, an unspecified CML code may be more appropriate.
• Distinguish from CML in remission (C92.11) or CML in relapse (C92.12); the key is the current remission status.
• Always sequence this code as the primary diagnosis when it is the reason for the encounter or treatment.